Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
21 results
D3.101 - Etoricoxib Associated Fixed Drug Eruption: A Case Series from a Tertiary Allergy and Clinical Immunology Centre, United Arab Emirates
D3.93 - Clinical Efficacy of Tezepelumab in a Patient with Severe Refractory Mixed Asthma: A Case Report from Kazakhstan
D3.95 - Hidden in everyday cosmetics: Facial allergic contact dermatitis to fragrances
D3.97 - Allergic contact dermatitis confirmed by repeated open application test in a 68‑year‑old patient
D3.98 - An extended study for the multiple detection of IgE-mediated allergic reactions using microarray technology
D3.104 - Molecular Co-Sensitization Mapping Using a 192-Line Multiplex IgE Platform
D3.105 - Analysis of post-vaccination immunity in children with dermatology diseases receiving biologic and immunosuppressive therapy
D3.107 - Comparison of Cupressaceae sensitization allergens in a large Spanish cohort
D3.103 - Comprehensive Allergen Characterization for Standardized Basophil Activation Testing
D2.232 - Aquagenic Urticaria: High Atopic Comorbidity, Familial Aggregation, and Differential Water Reactivity
D2.233 - Epidemiology, Patient Characteristics, and Treatment Responses of Chronic Urticaria in Türkiye: A Systematic Literature Review
D2.237 - Patient-reported changes in urticaria activity after tattoo placement
D2.238 - Bilastine fast onset and strong peripheral antihistaminic activity: comparison with oral second-generation antihistamines and intramuscular dexchlorpheniramine in histamine-induced wheal and flare models
D2.239 - Oral and parenteral bilastine, fast onset and strong peripheral antihistaminic activity: comparison with oral second-generation antihistamines and intramuscular dexchlorpheniramine in wheal and flare models
D2.241 - Successful Slow Desensitization to Niraparib Following Failed Olaparib Desensitization in a Patient with Ovarian Cancer
D2.242 - Chronic Urticaria and Thyroid Disease: Analysis of Clinical, Laboratory Data and Therapeutic Response in the Mediterranean Area of Tarragona
D2.243 - Impact of simultaneous skin clearance and itch relief with lebrikizumab in patients with atopic dermatitis: post-hoc analysis from ADvocate1/2
D2.229 - Food Allergy in Ukrainian Children: Risk Factors, Early Allergen Introduction and Natural History
D2.234 - Mimicry of delayed pressure urticaria. Clinical case reports
D2.235 - Urticaria Voices: Patient-reported disease burden and treatment experiences in Chronic Spontaneous Urticaria in China - A real-world evidence study (UV in China)
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download